Preferred segments of neural thread protein

Details Preferred segments of neural thread protein Preferred segments of neural thread protein

2007-08-21

2007-08-21

Kemmerer, Elizabeth (Department: 1649)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

C530S330000

Reexamination Certificate

active

09697590

ABSTRACT:
The invention is directed to preferred repeat sequences of Neural Thread Protein (NTP), peptides, mimetics, antibodies, and nucleic acids of the preferred sequences, and diagnostic and therapeutic methods of using such preferred NTP sequences.

REFERENCES:
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5084559 (1992-01-01), Profy
patent: 5100788 (1992-03-01), Lofdahl et al.
patent: 5830670 (1998-11-01), de la Monte et al.
patent: 5834287 (1998-11-01), Kubota et al.
patent: 5948634 (1999-09-01), De la Monte et al.
patent: 6013763 (2000-01-01), Braisted et al.
patent: 6610506 (2003-08-01), Lo et al.
patent: 0 068 375 (1983-01-01), None
patent: 90/06993 (1990-06-01), None
patent: WO 96/14334 (1996-05-01), None
patent: WO96/18646 (1996-06-01), None
patent: WO99/16710 (1999-04-01), None
patent: WO 00/01720 (2000-01-01), None
patent: WO 00/55198 (2000-09-01), None
patent: WO 00/58495 (2000-10-01), None
patent: WO 02/092115 (2002-11-01), None
Rosen et al., WO 00/55199 published Sep. 21, 2000, p. 1 and 74, SEQ ID No. 123.
Motter et al., “Reduction of β-Amyloid Peptide42in the Cerebrospinal Fluid of patients with Alzheimer's Disease”, Annals of Neurology, 38(4):643-648, (1995), Amer. Neurological Assoc.
Molsa et al., “Validity of clinical diagnosis in dementia: a prospective clinicopathological study”, J. Neuro. & Psych, 48:1085-1090, (1985), British Medical Assoc.
Rocca et al. “Epidemiology of Clinically Diagnosed Alzheimer's Disease”, Ann. Neurol 19:415-424, (1986), Nat'l. Inst. Of Health.
Burns et al. “Accuracy of clinical diagnosis of Alzheimer's disease”, 301:1026, (1990), Inst. Of Psychiatry.
Risse et al., “Neuropathological findings in patients with clinical diagnoses of probable alzheimer's disease”, Am. J. Psychiatry 147(2):168-172, (1990), Amer. Psychiatric Assoc.
Gilleard et al., “The St. George's dementia bed investigation study: a comparison of clinical and pathological Diagnosis”, Acta Psychiatrica Scandinavica, 85(4):264-269, 1992, Dept. of Geriatric Medicine.
Mendez et al., “Clinically diagnosed Alzheimer Disease: Neuropathologic findings in 650 Cases”, Alzheimer Disease and Assoc. Disorders, 6(1):35-43, 1992, Raven Press, Ltd.
Fleming et al., “Dementia: Diagnosis and Evaluation”, Mayo Clin. Proc. 70:1093-1107, (1995), Mayo Foundtn. For Medical Education Research.
Bloom et al., “Diagnosis and evaluation of dementia”, Neurology 45:211-218, (1995), Amer. Academy of Neurology.
Bowler et al., “Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease”, Neurol. Neurosurg Psychiatry, 64:18-24, (1998), BMJ Publishing Group.
Jost et al. “The natural History of Alzheimer's Disease: A Brian Bank Study”, JAGS 43:1248-1255, (1995) The American Geriatrics Society.
Growdon et al., Ronald & Nancy Reagan “Consensus report of the working group on: Molecular and Biochemical Markers of Alzheimer's Disease”, Neurobiology of Aging, 19(2):109-116, (1998), Elsevier Sci. Inc.
Myers et al., “Apolipoprotein E ε4 association with dementia in a population-based study”, Neurology 46:673-677, 1996, American Academy of Neurology.
Pirttila et al., “Soluble amyloid β-protein in the cerebrospinal fluid from patients with Alzheimer's disease, Vascular dementia and controls”, J. of Neurological Sciences, 127:90-95, (1994), Elsevier Science B.V.
Arai et al., “Tau in Cerebrospinal Fluid: A potential diagnostic marker in Alzheimer's Disease”, Ann. Neurol. 38:649-652, (1995), Amer. Neurological Assoc.
Jensen et al., “Increased cerebrospinal fluid tau in patients with Alzheimer's disease”, Neuroscience Letters, 186:189-191, (1995), Elsevier Science Ireland Ltd.
Munroe et al., “Tau Protein in Cerebrospinal Fluid as an Aid in the Diagnosis of Alzheimer's Disease” Annals of Clinical & Laboratory Science, 25(3):207-217, (1995), Inst. For Clinical Science, Inc.
Tato et al., “Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type”, J. of Neurology, Neurosurgery, & Physchiatry, 59(3):280-283 (1995), BMJ Publishing Group.
T. Iwatsubo, “Amyloid β Protein in Plasma as a Diagnostic marker for Alzheimer's Disease”, Neurobiology of Aging, 19(2):161-163, (1998), Elsevier Science Inc.
Vigo-Pelfrey et al., “Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease”, Neurology 45:788-793, (1995), Advanstar Communications inc.
Nitsch et al., “Cerebrospinal fluid levels of Amyloid β-Protein in Alzheimer's disease: Inverse correlation with Severity of Dementia and effect of Apolipoprotein E Genotype”, Annals of Neurology, 37(4):512-518, (1995) American Neurological Association.
Van Gool et al., “Concentrations of Amyloid β protein in cerebrospinal fluid of patients with Alzheimer's Disease”, Annals of Neurology, 37(2):277-279, (1995), American Neurological Association.
Matsuura et al., “Autosomal dominant spastic paraplegia linked to chromosome 2p: clinical and genetic studies Of a large Japanese pedigree”, J. of Neurological Sciences, 151:65-70, (1997), Elsevier Science B.V.
Pirttila et al., “Cerebrospinal fluid concentrations of soluble Amyloid β-protein and apoliporotein E in patients With Alzheimer's disease”, Arch. Neurol. 53:189-193, (1996), American Medical Association.
Scinto et al., “A Ptential noninvasive neurobiological test for Alzheimer's disease”, Science 266:1051-1054 (1994), American Association for the Advancement of Science.
Growdon et al., “Pupil dilation tropicamide is not specific for Alzheimer's disease”, Arch Neirol. 54:841-844 (1997), American Medical Association.
Kennard et al., “Serum levels for the iron binding protein p97 are elevated in Alzheimer's disease”, Nature Medicine, 2(11):1230-1235 (1996), National Library of Medicine.
De la Monte et al., “Characterization of the AD7C-NTP cDNA Expression in Alzheimer's Disease and Measurement of a 41-kD protein in Cerebrospinal fluid”, J. Clin. Invest. 100(12):3093-3104, (1997) American Society for Clinical Investigation, Inc.
De la Monte et al., “AD7c-NTP biomarker for Alzheimer's disease”, Alzheimer's Reports 2(6):327-332, (1999) National Library of Medicine.
Ozturke et al., “Elevated levels of an exocrine pancreatic secretory protein in Alzheimer disease brain”, Proc. Nat'l. Acad. Sci., 86:419-423, (1989), Molecular Hepatology Laboratory.
De la Monte et al., “Enhanced expression of an Exocrine pancreatice protein in Alzheimer's disease and the Developing human brain”, J. Clin. Invest., 86:1004-1013, (1990), Amer. Society for Clinical Invest. Inc.
De la Monte et al., “Increased levels of Neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease”, Ann Neurol 32(6):733-742 (1992), Amer. Neurological Assoc.
De la Monte et al., “Profiles of Neuronal thread protein expression in Alzheimer's disease”, J. Neuro. & Experimental Neurology, 55(10):1038-1050, (1996), American Assoc. of Neuropathologies.
De la Monte et al. “Modulation of neuronal thread protein expression with neuritic sprouting: relevance to Alzheimer's disease”, J. of Neurological Sciences 138:26-35, (1996), Elsevier Science B.V.
De la Monte et al., “Developmental patterns of neuronal thread protein gene expression in down syndrome”, J. of Neurological Sciences, 135:118-125, (1996), Elsevier Science B.V.
Chong et al., “Automated Microparticle Enzyme Immunoassay for Neural thread protein in cerebrospinal Fluid from Alzheimer's disease patients”, J. Clinical Lab. Analysis, Λ;379-383 (1992), Wiley-Liss, Inc.
Ghanbari et al., “A sandwich enzyme immunoassay for measuring AD7C-NTP a

Affiliated with

Also associated with

Rating

Preferred segments of neural thread protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Preferred segments of neural thread protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preferred segments of neural thread protein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3827528